Koss-Olinger Consulting’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-9,300
| Closed | -$293K | – | 60 |
|
|
2023
Q4 | $293K | Hold |
9,300
| – | – | 0.03% | 240 |
|
|
2023
Q3 | $238K | Sell |
9,300
-4,675
| -33% | -$120K | 0.04% | 228 |
|
|
2023
Q2 | $401K | Hold |
13,975
| – | – | 0.05% | 154 |
|
|
2023
Q1 | $335K | Buy |
+13,975
| New | +$335K | 0.04% | 164 |
|
|
2021
Q4 | – | Sell |
-43,800
| Closed | -$2.09M | – | 219 |
|
|
2021
Q3 | $2.09M | Sell |
43,800
-15,000
| -26% | -$717K | 0.34% | 24 |
|
|
2021
Q2 | $1.99M | Buy |
58,800
+38,800
| +194% | +$1.31M | 0.3% | 37 |
|
|
2021
Q1 | $826K | Buy |
+20,000
| New | +$826K | 0.14% | 91 |
|